Overall survival in patients with interstitial lung abnormalities was intermediate between non-interstitial lung abnormalities and interstitial lung disease.
Imkeldi is a liquid formulation of imatinib that utilizes proprietary technology to allow for accurate dosing and an alternative formulation to tablets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results